Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy. [electronic resource]
Producer: 20090129Description: 3157-68 p. digitalISSN:- 1534-4681
- Adenocarcinoma -- drug therapy
- Aged
- Annexin A2 -- genetics
- Antimetabolites, Antineoplastic -- therapeutic use
- Blotting, Western
- Carcinoma, Adenosquamous -- drug therapy
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cell Survival -- drug effects
- Chemotherapy, Adjuvant
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Immunoenzyme Techniques
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local -- diagnosis
- Pancreatic Neoplasms -- drug therapy
- Prognosis
- RNA, Messenger -- genetics
- RNA, Small Interfering -- pharmacology
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
- Tumor Cells, Cultured
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.